Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

Minimal clinically important differences of disease activity indices in childhood-onset systemic lupus erythematosus.

Brunner HI, Higgins GC, Klein-Gitelman MS, Lapidus SK, Olson JC, Onel K, Punaro M, Ying J, Giannini EH.

Arthritis Care Res (Hoboken). 2010 Jul;62(7):950-9. doi: 10.1002/acr.20154.

2.

Prospective validation of the provisional criteria for the evaluation of response to therapy in childhood-onset systemic lupus erythematosus.

Brunner HI, Higgins GC, Wiers K, Lapidus SK, Olson JC, Onel K, Punaro M, Ying J, Klein-Gitelman MS, Giannini EH.

Arthritis Care Res (Hoboken). 2010 Mar;62(3):335-44. doi: 10.1002/acr.20103.

3.

The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.

American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria.

Arthritis Rheum. 2004 Nov;50(11):3418-26.

5.

Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.

Castrejón I, Tani C, Jolly M, Huang A, Mosca M.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-85-95. Epub 2014 Oct 30. Review.

PMID:
25365095
6.

Lupus Impact Tracker is responsive to physician and patient assessed changes in systemic lupus erythematosus.

Giangreco D, Devilliers H, Annapureddy N, Block JA, Jolly M.

Lupus. 2015 Dec;24(14):1486-91. doi: 10.1177/0961203315593168. Epub 2015 Jul 9.

PMID:
26162686
8.
9.

Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials.

Touma Z, Gladman DD, Ibañez D, Taghavi-Zadeh S, Urowitz MB.

J Rheumatol. 2011 Nov;38(11):2395-9. doi: 10.3899/jrheum.110550. Epub 2011 Sep 1.

PMID:
21885488
10.
11.

Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians.

Chang E, Abrahamowicz M, Ferland D, Fortin PR; CaNIOS Investigators.

J Clin Epidemiol. 2002 May;55(5):488-97.

PMID:
12007552
12.

Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus.

Hersh AO, von Scheven E, Yazdany J, Panopalis P, Trupin L, Julian L, Katz P, Criswell LA, Yelin E.

Arthritis Rheum. 2009 Jan 15;61(1):13-20. doi: 10.1002/art.24091.

13.

Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.

Brunner HI, Gladman DD, Ibañez D, Urowitz MD, Silverman ED.

Arthritis Rheum. 2008 Feb;58(2):556-62. doi: 10.1002/art.23204.

14.

The use of the British Isles Lupus Assessment Group (BILAG) index as a valid tool in assessing disease activity in childhood-onset systemic lupus erythematosus.

Marks SD, Pilkington C, Woo P, Dillon MJ.

Rheumatology (Oxford). 2004 Sep;43(9):1186-9. Epub 2004 Jun 29.

PMID:
15226518
15.

Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices.

Hui-Yuen JS, Reddy A, Taylor J, Li X, Eichenfield AH, Bermudez LM, Starr AJ, Imundo LF, Buyon J, Furie RA, Kamen DL, Manzi S, Petri M, Ramsey-Goldman R, van Vollenhoven RF, Wallace DJ, Askanase A.

J Rheumatol. 2015 Dec;42(12):2288-95. doi: 10.3899/jrheum.150470. Epub 2015 Nov 1.

16.
17.

Outcome measures to be used in clinical trials in systemic lupus erythematosus.

Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P.

J Rheumatol. 1999 Feb;26(2):490-7.

PMID:
9972993
18.

Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage.

Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM.

Arthritis Rheum. 2002 Feb;46(2):436-44.

PMID:
11840446
19.

Response to hydroxychloroquine in Japanese patients with systemic lupus erythematosus using the cutaneous lupus erythematosus disease area and severity index (CLASI).

Yokogawa N, Kato Y, Sugii S, Inada S.

Mod Rheumatol. 2012 Apr;22(2):249-55. doi: 10.1007/s10165-011-0503-y. Epub 2011 Aug 14.

PMID:
21842436
20.

Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus.

Mina R, Klein-Gitelman MS, Nelson S, Eberhard BA, Higgins G, Singer NG, Onel K, Tucker L, O'Neil KM, Punaro M, Levy DM, Haines K, Martini A, Ruperto N, Lovell D, Brunner HI.

Ann Rheum Dis. 2014 Feb;73(2):401-6. doi: 10.1136/annrheumdis-2012-202376. Epub 2013 Jan 23.

PMID:
23345596

Supplemental Content

Support Center